SAC Capital Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

SAC Capital Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-604,900	Closed	-$10.2M	–	2217
2013 Q4	$10.2M	Buy	604,900 +356,422	+143%	+$4.93M	0.06%	365
2013 Q3	$2.64M	Buy	+248,478	New	+$2.17M	0.01%	672

Other funds holding ANAC

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SAC Capital Advisors's ANAC Position: Q1 2014 in Review

SAC Capital Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2014, closing a stake of 604,900 shares — an estimated $10.2M sold.

SAC Capital Advisors first reported a position in ANAC in Q3 2013 and held it in 2 quarters. The position peaked at $10.2M in Q4 2013. 105 funds tracked by Wall St. Rank hold ANAC as of Q1 2014.

SAC Capital Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2014 after selling out during the quarter.
SAC Capital Advisors sold 604,900 ANACOR PHARMACEUTICALS INC COM shares in Q1 2014, an estimated $10.2M.
SAC Capital Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 2 quarters.
SAC Capital Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $10.2M in Q4 2013.
105 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2014.

Based on SAC Capital Advisors's 13F filing for Q1 2014, filed 15 May 2014.